Jun-ichi Yasumoto
Nara Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jun-ichi Yasumoto.
Cancer Research | 2004
Akihisa Takahashi; Hideki Matsumoto; Kosuke Nagayama; Mutsuko Kitano; Sayako Hirose; Hidenori Tanaka; Eiichiro Mori; Nobuhiro Yamakawa; Jun-ichi Yasumoto; Kazue Yuki; Ken Ohnishi; Takeo Ohnishi
To identify critical events associated with heat-induced cell killing, we examined foci formation of γH2AX (histone H2AX phosphorylated at serine 139) in heat-treated cells. This assay is known to be quite sensitive and a specific indicator for the presence of double-strand breaks. We found that the number of γH2AX foci increased rapidly and reached a maximum 30 minutes after heat treatment, as well as after X-ray irradiation. When cells were heated at 41.5°C to 45.5°C, we observed a linear increase with time in the number of γH2AX foci. An inflection point at 42.5°C and the thermal activation energies above and below the inflection point were almost the same for cell killing and foci formation according to Arrhenius plot analysis. From these results, it is suggested that the number of γH2AX foci is correlated with the temperature dependence of cell killing. During periods when cells were exposed to heat, the cell cycle-dependent pattern of cell killing was the same as the cell cycle pattern of γH2AX foci formation. We also found that thermotolerance was due to a depression in the number of γH2AX foci formed after heating when the cells were pre-treated by heat. These findings suggest that cell killing might be associated with double-strand break formation via protein denaturation.
Apoptosis | 2004
Kazue Yuki; Akihisa Takahashi; Ichiro Ota; Ken Ohnishi; Jun-ichi Yasumoto; Katsunari Yane; Hirokazu Kanata; Noritomo Okamoto; Hiroshi Hosoi; Takeo Ohnishi
To clarify effective chemotherapeutic regimens against cancer, we examined the effects of glycerol on apoptosis induced by CDDP treatment using cultured human cancer cells (in vitro) and transplanted tumor in mice (in vivo). Human tongue cell carcinoma (SAS) cells transfected with mutated p53 gene (SAS/mp53) showed CDDP-resistance compared with the cells with neo control gene (SAS/neo). When those cultured cells were pre-treated with glycerol, CDDP-induced apoptosis was enhanced by glycerol in SAS/mp53 cells but not in SAS/neo cells.In tumor-transplanted mice, the glycerol treatment to tumors enhanced growth delay induced by CDDP in mp53 tumors transplanted with SAS/mp53 cells, but not in wtp53 tumors transplanted with SAS/neo cells. When transplanted tumors were treated with CDDP alone, the cells positive for active caspase-3, 85kDa PARP and apoptosis were observed by immunohistochemical staining in wtp53 tumors but not in mp53 tumors. When the tumors were treated with CDDP combined with glycerol, positive cells were observed not only in wtp53 tumors but also in mp53 tumors. These results showed that the CDDP-induced growth inhibition of the tumors is p53-dependent and that the enhanced growth delay by glycerol may be due to the increased apoptosis. Glycerol might be available for cancer chemotherapy in patients with m{p53} tumors.
International Journal of Hyperthermia | 2008
Atsuhisa Kajihara; Akihisa Takahashi; Ken Ohnishi; Yuichiro Imai; Nobuhiro Yamakawa; Jun-ichi Yasumoto; Takeo Ohnishi; Tadaaki Kirita
Purpose: Hyperthermia is useful in the treatment of human head and neck cancers, because it is relatively easy to regulate temperatures when compared to tumors located in deep organs. In this study, attention was focused on p53 as a possible predictive indicator for the efficacy of hyperthermic cancer therapy. Methods: Two kinds of cell lines were used. These were derived from a human squamous cell carcinoma (SAS) and had identical genetic backgrounds except for their p53 gene status. It was previously reported that the heat sensitivity and frequency of apoptosis in wild-type p53 cells (SAS/neo) were clearly elevated when compared with mutated p53 cells (SAS/mp53). In order to study the expression of apoptosis related proteins after heat treatment, protein microarray analysis was used. Results: The expression of apoptosis inhibitory proteins such as Bcl-2, Bcl-xL, NF-κB, COX2, STAT3, IL-6, and IKKα/1 was seen to increase after heat treatment in SAS/mp53 cells, but not in SAS/neo cells. Conclusion: The result of these observations indicates that apoptosis inhibitory proteins (such as Bcl-2, Bcl-xL, IL-6, etc.) were highly induced in SAS/mp53 cells after heat treatment when compared to control SAS/neo cells.
Apoptosis | 2004
Ken Ohnishi; H. Inaba; Jun-ichi Yasumoto; Kazue Yuki; Akihisa Takahashi; Takeo Ohnishi
We propose here a novel p53-targeting radio-cancer therapy using p53 C-terminal peptides for patients having mutated p53. Hoechst 33342 staining showed that X-ray irradiation alone efficiently induced apoptotic bodies in wild-type p53 (wtp53) human head and neck cancer cells transfected with a neo control vector (SAS/neo cells), but hardly induced apoptotic bodies in mutation-type p53 (mp53) cells transfected with a vector carrying the mp53 gene (SAS/mp53). In contrast, transfection of p53 C-terminal peptides (amino acid residues 361-382 or 353-374) via liposomes caused a remarkable increase of apoptotic bodies in X-ray-irradiated SAS/mp53 cells, but did not enhance apoptotic bodies in X-ray-irradiated SAS/neo cells. In immunocytochemical analysis, positively stained cells for active type caspase-3 were observed at high frequency after X-ray irradiation in the SAS/mp53 cells pre-treated with p53 C-terminal peptides. In SAS/neo cells, positively stained cells for active type caspase-3 were observed with X-ray irradiation alone. Furthermore, protein extracts from X-ray-irradiated SAS/mp53 cells showed higher DNA-binding activity of p53 to p53 consensus sequence when supplemented in vitro with p53 C-terminal peptides than extracts from non-irradiated SAS/mp53 cells. These results suggest that radiation treatment in the presence of p53 C-terminal peptides is more effective for inducing p53-mediated apoptosis than radiation treatment alone or p53 C-terminal peptide treatment alone, especially in mp53 cancer cells. This novel tool for enhancement of apoptosis induction in mp53 cells might be useful for p53-targeted radio-cancer therapy.
International Journal of Radiation Oncology Biology Physics | 2004
Akihisa Takahashi; Hideki Matsumoto; Kazue Yuki; Jun-ichi Yasumoto; Atsuhisa Kajiwara; Mizuho Aoki; Yoshiya Furusawa; Ken Ohnishi; Takeo Ohnishi
Cancer Letters | 2004
Jun-ichi Yasumoto; Tadaaki Kirita; Akihisa Takahashi; Ken Ohnishi; Yuichiro Imai; Kazue Yuki; Takeo Ohnishi
Journal of Radiation Research | 2003
Jun-ichi Yasumoto; Yuichiro Imai; Akihisa Takahashi; Ken Ohnishi; Kazue Yuki; Tadaaki Kirita; Takeo Ohnishi
International Journal of Oncology | 2006
Ken Ohnishi; Jun-ichi Yasumoto; Akihisa Takahashi; Takeo Ohnishi
Oral Oncology | 2005
Yuichiro Imai; Ken Ohnishi; Jun-ichi Yasumoto; Atsuhisa Kajiwara; Nobuhiro Yamakawa; Akihisa Takahashi; Takeo Ohnishi; Tadaaki Kirita
Oncology Reports | 2004
Kazue Yuki; Akihisa Takahashi; Ichiro Ota; Ken Ohnishi; Jun-ichi Yasumoto; Hirokazu Kanata; Katsunari Yane; Hiroshi Hosoi; Takeo Ohnishi